Effects of extracorporeal shock wave therapy and polysulfated glycosaminoglycan treatment on subchondral bone, serum biomarkers, and synovial fluid biomarkers in horses with induced osteoarthritis.
- Journal Article
- Randomized Controlled Trial
Summary
This research evaluates the impacts of extracorporeal shock wave therapy and polysulfated glycosaminoglycan treatment on the subchondral bone, serum biomarkers and synovial fluid biomarkers in horses suffering from introduced osteoarthritis.
Research Methods
The research involved a scientific experiment carried out on 24 healthy horses aged between 2 to 3 years. Methods employed included:
- Creating an osteochondral fragment on the distal aspect of the radial carpal bone in one middle carpal joint of each participating horse.
- Randomly assigning horses to receive either local application of extracorporeal shock wave therapy (ESWT), polysulfated glycosaminoglycan treatment (PSGAGT), or a placebo.
- Conducting serum biomarkers measurements every 7 days, and synovial fluid biomarkers measurements every 14 days.
- Measuring bone density using computed tomography on day 0 and day 70, with a comparison of microdamage and bone formation variables conducted among groups at the end of the study.
Results
The results from this research showed:
- No significant effect of either ESWT or PSGAGT on any bone variable.
- A significantly higher serum osteocalcin concentration in horses that received ESWT compared to those that received a placebo treatment.
- A significantly higher serum concentration of the C-terminal telopeptide of type I collagen in horses that received ESWT compared with horses that were given a placebo treatment or the PSGAGT.
- A significant increase in the concentration of the synovial fluid epitope CS846 in joints with osteoarthritis that were treated with ESWT.
Conclusions and Clinical Relevance
The research concluded that:
- ESWT treatment of osteoarthritis had no impact on the subchondral bone (SCB), however, it did lead to increases in serum biomarkers indicating bone remodeling.
- On the other hand, treating osteoarthritis with PSGAGT had no effect on either subchondral bone or biomarkers.
Therefore, while ESWT seems to bring about changes in serum biomarkers, neither of the examined treatment options (ESWT and PSGAGT) showed an impact on subchondral bone, suggesting they may not be effective in altering bone metrics in horses with artificially induced osteoarthritis.
Cite This Article
Publication
Researcher Affiliations
- Gail Holmes Equine Orthopaedic Research Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA. ckawcak@colostate.edu
MeSH Terms
- Animals
- Biomarkers / metabolism
- Carpus, Animal / injuries
- Carpus, Animal / pathology
- Cartilage, Articular / pathology
- Collagen Type II / metabolism
- Epitopes / blood
- Female
- Glycosaminoglycans / administration & dosage
- Glycosaminoglycans / therapeutic use
- High-Energy Shock Waves / therapeutic use
- Horse Diseases / blood
- Horse Diseases / pathology
- Horse Diseases / therapy
- Horses
- Lameness, Animal / blood
- Lameness, Animal / classification
- Lameness, Animal / therapy
- Male
- Osteoarthritis / blood
- Osteoarthritis / pathology
- Osteoarthritis / therapy
- Osteoarthritis / veterinary
- Synovial Fluid / chemistry
Citations
This article has been cited 10 times.- Boström A, Bergh A, Hyytiäinen H, Asplund K. Systematic Review of Complementary and Alternative Veterinary Medicine in Sport and Companion Animals: Extracorporeal Shockwave Therapy. Animals (Basel) 2022 Nov 12;12(22).
- Tellegen A, Beukers M, Rudnik-Jansen I, van Klaveren N, How KL, Woike N, Mihov G, Thies J, Teske E, Creemers L, Tryfonidou M, Meij B. Intra-Articular Slow-Release Triamcinolone Acetonide from Polyesteramide Microspheres as a Treatment for Osteoarthritis. Pharmaceutics 2021 Mar 11;13(3).
- Moser DK, Schoonover MJ, Sippel KM, Dieterly AM, Ritchey JW, Wall CR. Catastrophic complication following injection and extracorporeal shock wave therapy of a medial femoral condyle subchondral cystic lesion in a 14 year old Arabian mare. Open Vet J 2017;7(2):111-116.
- Zhang Y, Wang T, Cao Y. Osteopontin can decrease the expression of Col-II and COMP in cartilage cells in vitro. Int J Clin Exp Med 2015;8(2):2254-60.
- McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012 Nov;1(11):297-309.
- Qiu Z, Wang J, Zhang Y, Liu X, Wei C, Ma T. Extracorporeal shock wave therapy for equine musculoskeletal disorders: from biological mechanisms to clinical applications. Front Vet Sci 2025;12:1719123.
- Khadour FA, Khadour YA, Khouly OI, Dao X. Combined low-intensity pulsed ultrasound and extracorporeal shock wave therapy reduces pain and inflammation in knee osteoarthritis patients. Sci Rep 2025 Nov 29;16(1):1221.
- White GW. Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data. Open Vet J 2025 Sep;15(9):4007-4023.
- Liu S, Chen Q, Zhang Q, Tao K, Li C, Chang B, Wang W, Wu Z. Electroacupuncture combined with extracorporeal shock wave therapy improves pain symptoms and inflammatory factor levels in knee osteoarthritis patients. Heliyon 2023 Oct;9(10):e20771.
- O'Brien TJ, Hollinshead F, Goodrich LR. Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?. Extracell Vesicles Circ Nucl Acids 2023 Jun;4(2):151-169.